Left bundle branch block (LBBB) has been identified as an independent cause of non-ischemic cardiomyopathy. Rate-related LBBB is an infrequent finding on stress tests (0.5% incidence) and has been associated with a higher all-cause mortality. However, the progression of rate-related LBBB to cardiomyopathy has not been well studied. We conducted a retrospective chart review to assess the characteristics of patients with rate-related LBBB and predictors of cardiomyopathy in this population. We identified all patients with LBBB during stress testing at our tertiary hospital from 2008-2020. Further we included those who developed rate-related LBBB and had transthoracic echocardiography (TTE) to assess their left ventricular ejection fraction (LVEF). Patients with right bundle branch block, resting LBBB, stress QRS<120 milliseconds, no TTE and ischemic cardiomyopathy were excluded. A total of 694 patients had LBBB on stress testing. Among these, 34 patients developed rate-related LBBB and met entry criteria. Females comprised 64.7%. Treadmill, dobutamine and vasodilator stress tests were performed in 23 (68%), 5 (15%) and 6 (17.6%) patients, respectively. Analysis of continuous variables showed moderate correlation (r=-0.4, p= 0.02) between LVEF and maximum stress QRS duration (maxQRS) and no significant correlation (r=0.3, p=0.08) with heart rate at which LBBB starts (HRstart). Patients with LVEF<40% had a wider maxQRS in rate-related LBBB than those with higher LVEF (157±11 vs 144±13, p=0.04). LBBB was noted earlier at a numerically lower mean HRstart in the LVEF<40% group but was not significantly different from the higher EF group (105±27 vs 116±28, p=0.45). Pre and post-stress QRS duration, sex, hypertension, coronary artery disease, beta blocker use and ACEi/ARB/ARNI use were not significant predictors of cardiomyopathy. Rate-related LBBB is not benign. Wider QRS duration during rate-related LBBB was associated with left ventricular dysfunction among these patients. Further prospective studies with larger sample size are needed to explore management options for patients with rate-related LBBB.
Read full abstract